Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMIC: Antibiotics for Chronic Wet Cough
NCT06020716Phase 4Recruiting
- Sponsor
- Stavanger University Hospital
- Start
- Aug 2023
- Primary completion
- Apr 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of amoxicillin + clavulanate in Protracted bacterial bronchitis (PBB) (4 arms), sponsored by Stavanger University Hospital. Primary endpoint: Response to treatment. Started Aug 2023; status: recruiting.
02
Drugs
amoxicillin + clavulanate
03
Conditions
Protracted bacterial bronchitis (PBB)
Beyond the preview
Go deeper on NCT06020716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06020716.